Study of the Liver Function Tests' Predictive Value in the Early Diagnosis of Prediabetes at DMCH

Background: The early detection of prediabetes is crucial in preventing the progression of type 2 diabetes mellitus (T2DM). Liver function tests (LFTs), which include measures of enzymes like alanine aminotransferase (ALT) and aspartate aminotransferase (AST), have been increasingly recognized for their potential role in identifying metabolic disturbances associated with insulin resistance and prediabetes. This study explores the utility of LFTs in predicting prediabetes, potentially offering a simple, cost-effective screening tool for at-risk populations at DMCH. Method: The study conducted a cross-sectional analysis of patients attending the DMCH. We recruited people between the ages of 20 and 65 into two groups: 30 healthy individuals with normal blood sugar levels (normoglycemia) and 30 individuals with prediabetes. We compared liver function test (LFT) parameters across these groups. Statistical tests were employed for the analysis in this study. Result: Results revealed that ALT median was significantly increased in prediabetes compared to normoglycemia (19.5 vs. 13.8 IU/L, respectively; p = 0.002). For AST, there were no significant differences between the two groups investigated (p = 0.231). In the case of ALP, significantly increased medians were observed in prediabetes compared to normoglycemia (90.7 and 73.1 IU/L, respectively; p = 0.005). ROC curve analysis revealed that ALT (AUC = 0.891; 95% CI =0.688 – 0.894; p = 0.001; cut-off value = 16.1IU/L; sensitivity = 72.4%; specificity = 73.3%) and ALP (AUC = 0.824; 95% CI = 0.621 – 0.828; p = 0.001; cut-off value = 80.2 IU/L; sensitivity = 67.2%; specificity = 66.7%) were good predictors in differentiating between prediabetes and normoglycemia. Conclusion: This research concludes that ALT and ALP are effective predictors of prediabetes, but further research is needed to fully comprehend the mechanism underlying the link between liver function enzymes and diabetes risk.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-11-26
DOI
https://doi.org/10.5281/zenodo.14516852
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Study of the Liver Function Tests' Predictive Value in the Early Diagnosis of Prediabetes at DMCH

Zenodo (CERN European Organization for Nuclear Research)
Diabetes, Cardiovascular Risks, and Lipoproteins
article

Study of the Liver Function Tests' Predictive Value in the Early Diagnosis of Prediabetes at DMCH

article en

Abstract

Background: The early detection of prediabetes is crucial in preventing the progression of type 2 diabetes mellitus (T2DM). Liver function tests (LFTs), which include measures of enzymes like alanine aminotransferase (ALT) and aspartate aminotransferase (AST), have been increasingly recognized for their potential role in identifying metabolic disturbances associated with insulin resistance and prediabetes. This study explores the utility of LFTs in predicting prediabetes, potentially offering a simple, cost-effective screening tool for at-risk populations at DMCH. Method: The study conducted a cross-sectional analysis of patients attending the DMCH. We recruited people between the ages of 20 and 65 into two groups: 30 healthy individuals with normal blood sugar levels (normoglycemia) and 30 individuals with prediabetes. We compared liver function test (LFT) parameters across these groups. Statistical tests were employed for the analysis in this study. Result: Results revealed that ALT median was significantly increased in prediabetes compared to normoglycemia (19.5 vs. 13.8 IU/L, respectively; p = 0.002). For AST, there were no significant differences between the two groups investigated (p = 0.231). In the case of ALP, significantly increased medians were observed in prediabetes compared to normoglycemia (90.7 and 73.1 IU/L, respectively; p = 0.005). ROC curve analysis revealed that ALT (AUC = 0.891; 95% CI =0.688 – 0.894; p = 0.001; cut-off value = 16.1IU/L; sensitivity = 72.4%; specificity = 73.3%) and ALP (AUC = 0.824; 95% CI = 0.621 – 0.828; p = 0.001; cut-off value = 80.2 IU/L; sensitivity = 67.2%; specificity = 66.7%) were good predictors in differentiating between prediabetes and normoglycemia. Conclusion: This research concludes that ALT and ALP are effective predictors of prediabetes, but further research is needed to fully comprehend the mechanism underlying the link between liver function enzymes and diabetes risk.

Zenodo (CERN European Organization for Nuclear Research)
Darbhanga Medical College and Hospital (IN)
Good health and well-being
Openalex Percentile: Top 48%
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.